Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
24 May 2024 Job Information Organisation/Company University College Dublin Research Field Medical sciences » Medicine Researcher Profile First Stage Researcher (R1) Country Ireland Application Deadline 6 Jun 2024 - 01:05 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded...
-
5 Jun 2024 Job Information Organisation/Company University College Dublin Research Field Chemistry » Biochemistry Researcher Profile First Stage Researcher (R1) Country Ireland Application Deadline 2 Jul 2024 - 09:01 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through...
-
Conway Institute of Biomolecular & Biomedical Research | Dublin Bar, Leinster | Ireland | 27 days ago
institutions world-wide. The project aims to develop three-dimensional in vitro drug discovery pathophysiology models using appropriate human cells (e.g. diabetic, fibrosis, cancer, etc.). State-of-the-art
-
macrophages (an innate immune cell) contribute to kidney damage in autoimmunity (MacATAK). This is a multi-disciplinary training opportunity that includes basic biomedical research, state-of-the-art cellular
-
systems for optimizing T-cell therapies. The project will focus on investigating two types of cancers: liver cancer (HEPG2) and osteosarcoma (SaOS2). The primary objective is to demonstrate, in real-time
-
). The candidate will work with Lachnospiraceae strains isolated from healthy individuals to examine their anti-inflammatory potential in intestinal epithelial cell systems including cell lines and organoids (3D
-
Lachnospiraceae strains isolated from healthy individuals to examine their anti-inflammatory potential in intestinal epithelial cell systems including cell lines and organoids (3D mini-guts) and in animal models
-
Medicine, with particular focus in musculoskeletal (e.g. tendon, bone, cartilage) bioengineering. Direct cell injections were introduced in regenerative medicine as a means to restore lost tissue function
-
: expanding the target cohort for immune checkpoint inhibition. The target of immune checkpoint inhibition is the preactivated antigen-specific T cells. Our research group were among the first to report novel
-
to cells. One Research Assistant will focus on analysis of the composition of concentrated eVLP preparations and factors that affect transduction efficiency and editing efficacy. Dynamic collaboration exists